【CKD】《Aptar》攜手《AstraZeneca》開發AI早期篩檢「慢性腎臟病」

 【CKD】《Aptar》攜手《AstraZeneca》開發AI早期篩檢「慢性腎臟病」

 文章出處  

Businesswire 

 

 原文標題  

Aptar Digital Health Announces Licensing Agreement With AstraZeneca to Develop AI-Powered Screening Algorithms 

 

 Twitter  

https://x.com/aimedadviser/status/1927118139558392286 

 

 文章序號  

8086 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.